drugset / Trial / NCT04141020
Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms
Phase 2
Recruiting
80 enrolled
University of Miami
National Institute of Neurological Disorders and Stroke (NINDS) · collab
Non-randomizedParallel-groupSingle-blindBasic science
Summary
The objective of this study is to explore the effects of Sirolimus on the underlying molecular alterations of cerebral aneurysms.
Timeline
- Start
- 2021-10-27
- Primary completion
- 2026-11-01
- Completion
- 2026-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sirolimus | Small molecule | 2 mg | Oral |